Anatomic Pathology Market Size, Share, Growth Report 2030

Anatomic Pathology Market

Anatomic Pathology Market - By Products & Services (Instruments and Consumables), By Application (Disease Diagnosis and Drug Discovery & Development), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Category: Healthcare Report Format : PDF Pages: 130 Report Code: ZMR-6245 Published Date: May-2021 Status : Published
Market Size in 2019 Market Forecast in 2026 Growth Rate (in %) Base Year
USD 16.1 billion USD 21.2 billion CAGR at 6% 2019

Anatomic Pathology Market Size

The global Anatomic Pathology market accrued earnings worth approximately 16.1(USD Billion) in 2019 and is predicted to gain revenue of about 21.2(USD Billion) by 2026, is set to record a CAGR of nearly 6% over the period from 2020 to 2026. The report offers assessment and analysis of the Anatomic Pathology market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).

Introduction

Anatomic pathology is a domain in the medical sector that deals with disease diagnosis depending upon immunologic, macroscopic, molecular, microscopic, biochemical, and molecular examining of cells, organs, and tissues. Furthermore it is one of the two branches of pathology and includes gross examination, immunohistochemistry, cytopathology, histopathology, in situ hybridization, flow immunophenotyping, and tissue Cytogenetics. Apparently, rise in the cancer cases as well as other chronic ailments along with massive research on developing effective personalized drugs will boost the expansion of anatomic pathology industry over the assessment period. In addition to this, favorable compensation policies are anticipated to result in humungous market demand over the years ahead.

Market Growth Dynamics

Massive dependence on biomarker-based pathological tests & methods for exploring tumorigenesis & malignancy will steer the anatomic pathology market trends. In addition to this, large-scale utilization of new pathology devices such as digital microscopes, staining equipment, and imaging tools for enhancing anatomic pathology practices will drive the business growth.  Apparently, surge in the aging population prone to chronic disorders will prompt the industry expansion over 2020-2026. Additionally, escalating awareness about the significance of anatomic pathology across the globe will proliferate the anatomic pathology market size over the assessment period. Rise in the patient population base in the emerging economies as well as a steep increase in the healthcare expenditure will inflate the market value over the years to come. Nonetheless, easy access to refurbished medical products along with increase in product recalls will hinder the industry expansion over estimated timeline.

Anatomic Pathology Market: Report Scope

Report Attributes Report Details
Report Name Anatomic Pathology Market Research Report
Market Size in 2019 USD 16.1 billion
Market Forecast in 2026 USD 21.2 billion
Growth Rate CAGR of 6%
Number of Pages 130
Key Companies Covered F. Hoffmann-La Roche Ltd. (Switzerland), Diapath S.p.A. (Italy), Bio SB (U.S.),  Sakura Finetek (Japan), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Hologic, Inc. (U.S.), Becton, Dickinson and Company (U.S.), PHP Holdings Corporation (Japan),  Merck KGaA (Germany), and BioGenex Laboratories (U.S.).
Segments Covered By Products & Services, By Application, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2019
Historical Year 2017 to 2019
Forecast Year 2020 - 2026
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

North America Market To Continue Dominance Over 2020-2026

The expansion of anatomy pathology industry in the sub-continent over 2020-2026 is due to launching of new technologies in healthcare sector and favorable government schemes for cancer testing. In addition to this, supportive compensation policies & packages for anatomic pathology tests as well as huge spending on healthcare activities will embellish the regional market trends. Furthermore, presence of strong healthcare infrastructure for clinics as well as medical labs will proliferate the expansion of anatomic pathology industry in the sub-continent over the anticipated timeline.

Key players profiled in the report include: 

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Diapath S.p.A. (Italy)
  • Bio SB (U.S.)
  • Sakura Finetek (Japan)
  • Danaher Corporation (U.S.)
  • Agilent Technologies (U.S.)
  • Hologic, Inc. (U.S.)
  • Becton
  • Dickinson and Company (U.S.)
  • PHP Holdings Corporation (Japan)  
  • Merck KGaA (Germany)
  • BioGenex Laboratories (U.S.)

The global Anatomic Pathology Market is segmented as follows:

By Products & Services

  • Instruments
  • Consumables

By Application

  • Disease Diagnosis
  • Drug Discovery & Development

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Massive dependence on biomarker-based pathological tests & methods for exploring tumorigenesis & malignancy will steer the anatomic pathology market trends. In addition to this, large-scale utilization of new pathology devices such as digital microscopes, staining equipment, and imaging tools for enhancing anatomic pathology practices will drive the business growth.  Apparently, surge in the aging population prone to chronic disorders will prompt the industry expansion over 2020-2026. Additionally, escalating awareness about the significance of anatomic pathology across the globe will proliferate the anatomic pathology market size over the assessment period. Rise in the patient population base in the emerging economies as well as a steep increase in the healthcare expenditure will inflate the market value over the years to come.

According to Zion market research report, the global Anatomic Pathology market accrued earnings worth approximately 16.1(USD Billion) in 2019 and is predicted to gain revenue of about 21.2(USD Billion) by 2026, is set to record a CAGR of nearly 6% over the period from 2020 to 2026.

 

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to expansion of anatomy pathology industry in the sub-continent over 2020-2026 is due to launching of new technologies in healthcare sector and favorable government schemes for cancer testing. In addition to this, supportive compensation policies & packages for anatomic pathology tests as well as huge spending on healthcare activities will embellish the regional market trends. Furthermore, presence of strong healthcare infrastructure for clinics as well as medical labs will proliferate the expansion of anatomic pathology industry in the sub-continent over the anticipated timeline.

 

The key market participants include F. Hoffmann-La Roche Ltd. (Switzerland), Diapath S.p.A. (Italy), Bio SB (U.S.), Sakura Finetek (Japan), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Hologic, Inc. (U.S.), Becton, Dickinson and Company (U.S.), PHP Holdings Corporation (Japan), Merck KGaA (Germany), and BioGenex Laboratories (U.S.).

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed